666 Ivacaftor boosts cystic fibrosis transmembrane conductance regulator–mediated nasal potential difference in cystic fibrosis transmembrane conductance regulator knockout mice tr...

por Mukherjee, A., MacDonald, K., Eygeris, Y., Lokras, A., Sahay, G.
Publicado 2022

Low dose novel PARP-PI3K inhibition via nanoformulation improves colorectal cancer immunoradiotherapy

por Landry, M.R., DuRoss, A.N., Neufeld, M.J., Hahn, L., Sahay, G., Luxenhofer, R., Sun, C.
Publicado 2020